Glaucoma and Cataract Surgery Market to Surpass USD 8.3 Billion by 2035 Driven by Aging Population and Surgical Advancements

The global glaucoma and cataract surgery market is witnessing steady growth, projected to expand from USD 4.0 Billion in 2024 to USD 8.3 Billion by 2035, at a compound annual growth rate (CAGR) of 7.8%. Increasing geriatric populations, coupled with innovations in ophthalmic surgical technologies, are expected to drive the market forward over the forecast period.

As two of the most prevalent eye conditions worldwide, glaucoma and cataracts significantly impact vision and quality of life, especially among the elderly. Advances in minimally invasive procedures and lens technologies are contributing to faster recovery times, improved outcomes, and growing demand for surgeries.

To explore the complete market insights, visit Prophecy Market Insights

Market Segmentation Overview

By product type, the market is divided into glaucoma surgical devices and cataract surgical devices. The glaucoma segment includes implants, drainage devices, laser instruments, and other minimally invasive technologies. Meanwhile, cataract surgical devices comprise intraocular lenses (IOLs), ophthalmic viscoelastic devices, phacoemulsification systems, and others—each playing a vital role in efficient lens replacement procedures.

The market is also segmented by surgery type:

• Glaucoma surgeries: Conventional and Minimally Invasive Glaucoma Surgeries (MIGS) are reshaping the therapeutic landscape with reduced complication rates.
  
  

• Cataract surgeries: Techniques like phacoemulsification, femtosecond laser-assisted surgery, and extracapsular cataract extraction (ECCE) are gaining traction due to enhanced precision and patient comfort.

End-User Analysis

The major end-users of these surgical technologies include:

• Hospitals
  
  

• Ophthalmology Clinics
  
  

• Outpatient Surgery Centers
  
  

• Other specialized surgical facilities
  

Hospitals continue to dominate due to their advanced infrastructure, although outpatient and ambulatory surgery centers are emerging as preferred choices due to lower costs and shorter procedure times.

Market Drivers and Opportunities

Key drivers shaping the glaucoma and cataract surgery market include:

• Rising elderly population globally, particularly in Asia-Pacific and Europe, leading to increased incidence of age-related vision disorders.
  
  

• Growing prevalence of diabetes, a known risk factor for both glaucoma and cataract development.
  
  

• Technological advancements, such as femtosecond lasers and MIGS, improving the safety and effectiveness of surgical interventions.
  
  

Additionally, public health campaigns and awareness initiatives by governments and non-profits are encouraging early diagnosis and timely treatment, creating favorable market conditions.

Competitive Landscape

The market is highly competitive, with established players focused on R&D, strategic partnerships, and regional expansion. Key players include:

• Alcon Inc.
  
  

• NIDEK CO., LTD.
  
  

• Johnson & Johnson Services, Inc.
  
  

• Glaukos Corporation
  
  

• Essilor Solutions
  
  

• AbbVie Inc.
  
  

• Santen Pharmaceutical Co., Ltd.
  
  

• ASG Hospital Pvt. Ltd.
  
  

• Abbott
  
  

• Bausch + Lomb
  
  

• Carl Zeiss Meditec AG
  
  

• TOPCON CORPORATION
  
  

• New World Medical, Inc.
  
  

• Lumenis Be Ltd.
  

These companies are investing in laser-assisted surgery platforms, IOL customization technologies, and surgical robotics to gain a competitive edge.

Market Outlook

As the global burden of ocular disorders continues to grow, the glaucoma and cataract surgery market stands at the forefront of ophthalmic innovation. With rising accessibility, technological refinement, and increasing patient awareness, the industry is positioned for sustained growth over the next decade.

---

Author: Prophecy Market Insights